期刊文献+

阻断转化生长因子—β_1信号传导治疗大鼠实验性肝纤维化 被引量:28

Obstruction of TGF-β_1 signal transduction by anti-Smad4 gene can therapy experimental liver fibrosis in the rat
原文传递
导出
摘要 目的 观察腺病毒介导的反义Smad4基因阻断转化生长因子—β_1(TGF—β_1)信号传导后对肝纤维化的治疗作用。 方法 将腺病毒介导的反义Smad4基因导入四氯化碳/乙醇诱导的大鼠纤维化肝脏,用RT-PCR及western方法观察Smad4的表达,并观察肝脏的病理变化和胶原表达。 结果 纤维化肝脏中Smad4的表达较正常肝脏明显增强,Ⅰ型胶原增多。经转基因处理后大鼠纤维化肝脏中Smad4的表达明显弱于未治疗的纤维化肝脏,Ⅰ型胶原减少;且治疗组肝脏纤维间隔也明显减少,纤维化程度明显减轻。 结论 腺病毒介导的反义Smad4基因能有效阻断TGF—β信号传导系统,减少细胞外基质的产生,从而减轻肝纤维化的程度。 Objective To study the therapeutic effects to block the TGF-β_1(transforming growth factor β_1) signal transduction by antisense Smad4 gene on experimental fibrotic liver. Methods Using the rat model of liver fibrosis induced by Carbon Tetrachloride(CCl_4)/ethanol, we transfected antisense Smad4 gene mediated by adenovirus via portal vein infusion into the liver, and observed the expression of Smad4 by Retro-Polymerase Chain Reaction (RT-PCR) and Western Blot. We also investigated the pathologic features and collagen expression. Results In the non-therapeutic cirrhotic liver, the expression of Smad4 mRNA was significantly increased than normal liver, and so was the collagen Ⅰ. After antisense Smad4 gene being transfccted, the expression of Smad4 mRNA and that of collagen Ⅰ in the therapeutic liver was significantly decreased, compared with the non-therapeutic cirrhotic liver. The fibrous degree of therapeutic liver was also reduced compared with the non-therapeutic fibrous liver. Conclusion These results indicate that because antisense Smad4 gene could block TGF-β_1 signal transduction by reducing the expression of Smad4, so it could inhibit the production of extracellular matrix(ECM) and improve hepatic fibrosis.
出处 《中华肝脏病杂志》 CAS CSCD 2004年第5期263-266,共4页 Chinese Journal of Hepatology
关键词 肝纤维化 转化生长因子-Β1 腺病毒 SMAD4 反义基因 大鼠 信号传导蛋白 Hepatic fibrosis Transforming growth factor-β Adenoviruses, human Smad4 Antisense Gene
  • 相关文献

参考文献11

  • 1Gressner AM, Weiskirchen R, Breitkopf K, et al. Roles of TGF-beta in hepatic fibrosis. Front Biosci, 2002, 7: 793-807.
  • 2Zimmerman CM, Padgett RW. Transforming growth factor beta signaling mediators and modulators. Gene, 2000, 249: 17-30.
  • 3Zhang Y, Musci T, Derynck R. The tumor suppressor Smad4/DPC4as a central mediator of Smad funtion. Curr Biol, 1997, 7: 270-276.
  • 4Kitamura Y, Ninomiya H. Smad expression of hepatic stellate cells in liver cirrhosis in vivo and hepatic stellate cell line in vitro. Pathol Iht, 2003, 53: 18-26.
  • 5George J, Roulot D, Koteliansky VE, et al. In vivo inhibition of rat stellate cell activation by soluble transforming grwoth factor beta type Ⅱ receptor: a potential new therapy for hepatic fibrosis. Proc Natl Acad Sci USA, 1999, 96: 12719-12724.
  • 6Marcel T, Grausz JD. The TMC worldwide gene therapy enrollment report, end 1996. Human Gene Ther, 1997, 8: 775-800.
  • 7Perrotte P, Wood M, Slaton JW, et al. Biosafety of in vivo adenovirus-p53 intravesical administration in mice. Urology, 2000, 56:155-159.
  • 8Futagawa Y, Okamoto T, Ohashi T, et al. Efficiency of adenovirusmediated gene transfer into hepatocytes by liver asanguineous perfusion method. Res Exp Med(Berl), 2000, 199: 263-274.
  • 9Sato M, Kakubari, M, Kawamura M, et al. The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced by thioacetamide. Biochem Pharmacol,2000, 59:681-690
  • 10Beljaars L, Molema G, Schuppan D, et al. Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor. J Biol Chem, 2000,275: 12743-12751.

共引文献34

同被引文献160

引证文献28

二级引证文献277

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部